creatine has been researched along with Cytomegalovirus Infections in 4 studies
Cytomegalovirus Infections: Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults.
| Excerpt | Relevance | Reference |
|---|---|---|
| "5 mg/kg with concomitant oral probenecid, saline prehydration, extended dosing intervals, and drug interruption for proteinuria (19 patients)." | 5.08 | (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue. ( Cundy, K; Drew, WL; Fisher, PE; Flaherty, J; Glutzer, E; Hannigan, J; James, C; Lalezari, JP; Martin, JC; Miner, D, 1995) |
| "In a prospective study of solid-organ transplant recipients (n = 22; 15 hepatic and 7 renal) receiving valganciclovir for cytomegalovirus (CMV) prophylaxis, electronic estimation of glomerular filtration rate (eGFR) underestimated the true GFR (24-h urine creatinine clearance) by >20% in 14/22 (63." | 3.79 | Electronic estimations of renal function are inaccurate in solid-organ transplant recipients and can result in significant underdosing of prophylactic valganciclovir. ( Angus, P; Grayson, ML; Gregory, D; Ierino, F; Pavlovic, J; Shelton, E; Testro, A; Torresi, J; Trevillyan, J; Urbancic, K; Whitlam, J, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Trevillyan, J | 1 |
| Angus, P | 1 |
| Shelton, E | 1 |
| Whitlam, J | 1 |
| Ierino, F | 1 |
| Pavlovic, J | 1 |
| Gregory, D | 1 |
| Urbancic, K | 1 |
| Torresi, J | 1 |
| Testro, A | 1 |
| Grayson, ML | 1 |
| Fanos, V | 1 |
| Locci, E | 1 |
| Noto, A | 1 |
| Lazzarotto, T | 1 |
| Manzoni, P | 1 |
| Atzori, L | 1 |
| Lanari, M | 1 |
| Lalezari, JP | 1 |
| Drew, WL | 1 |
| Glutzer, E | 1 |
| James, C | 1 |
| Miner, D | 1 |
| Flaherty, J | 1 |
| Fisher, PE | 1 |
| Cundy, K | 1 |
| Hannigan, J | 1 |
| Martin, JC | 1 |
| Lehoang, P | 1 |
| Girard, B | 1 |
| Robinet, M | 1 |
| Marcel, P | 1 |
| Zazoun, L | 1 |
| Matheron, S | 1 |
| Rozenbaum, W | 1 |
| Katlama, C | 1 |
| Morer, I | 1 |
| Lernestedt, JO | 1 |
1 trial available for creatine and Cytomegalovirus Infections
| Article | Year |
|---|---|
(S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Creatine; Cytomegalovirus | 1995 |
3 other studies available for creatine and Cytomegalovirus Infections
| Article | Year |
|---|---|
Electronic estimations of renal function are inaccurate in solid-organ transplant recipients and can result in significant underdosing of prophylactic valganciclovir.
Topics: Adult; Antiviral Agents; Creatine; Cytomegalovirus; Cytomegalovirus Infections; Electronic Data Proc | 2013 |
Urinary metabolomics in newborns infected by human cytomegalovirus: a preliminary investigation.
Topics: 3-Hydroxybutyric Acid; Adult; Aminoisobutyric Acids; Betaine; Creatine; Cytomegalovirus; Cytomegalov | 2013 |
Foscarnet in the treatment of cytomegalovirus retinitis in acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Creatine; Cytomegalovirus Infections; Drug Therapy, Combi | 1989 |